Perioperative management of apixaban in patients with advanced CKD undergoing a planned invasive procedure
Blood Adv
.
2024 Feb 13;8(3):732-735.
doi: 10.1182/bloodadvances.2023012380.
Authors
Gabriella Hrubesz
1
,
Kevin Dwyer
2
,
Daniel I McIsaac
3
4
,
Manish M Sood
4
5
,
Edward Clark
4
5
,
James Douketis
6
,
Marc Carrier
1
4
,
Joseph R Shaw
1
4
Affiliations
1
Division of Hematology, Department of Medicine, University of Ottawa, Ottawa, Canada.
2
Analytics, Ottawa Hospital Research Institute, Ottawa, Canada.
3
Department of Anesthesiology and Pain Medicine, University of Ottawa, Ottawa, Canada.
4
Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.
5
Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Canada.
6
Department of Medicine, McMaster University, Hamilton, Canada.
PMID:
38181766
PMCID:
PMC10847030
DOI:
10.1182/bloodadvances.2023012380
No abstract available
MeSH terms
Anticoagulants
Humans
Pyrazoles / adverse effects
Pyridones*
Renal Insufficiency, Chronic* / complications
Warfarin*
Substances
apixaban
Warfarin
Anticoagulants
Pyrazoles
Pyridones